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How do you evaluate 
macrocytosis without anemia?
Start with a detailed history, paying 
particular attention to medications and 
alcohol use (strength of recommendation 
[SOR]: B, prospective cohort studies). 
Blood testing can include a peripheral 
smear, evaluation for vitamin defi ciencies 
(especially B12 defi ciency), and liver function 
tests (SOR: B, inconsistent prospective 
cohort studies). Thyroid testing may 
be useful for older patients (SOR: B, 
prospective study). Reticulocyte count and 
bone marrow evaluation, although important 
to rule out hemolysis and myelodysplastic 
changes, may not be necessary for patients 
with isolated macrocytosis without anemia 
(SOR: B, prospective cohort studies). In 
unexplained macrocytosis, bone marrow 
evaluation may show early marrow 
changes, particularly in the elderly (SOR: B, 
prospective cohort study).
Evidence-based answer
Clinical commentary
When the cause isn’t clear, think alcohol
Macrocytosis without anemia is not that 
rare, in my experience, and the cause 
usually becomes clear with a medication 
history and a few laboratory tests, such 
as vitamin B12 studies and thyrotropin. 
When I see a patient with macrocytosis 
without an obvious cause, I think of 
alcohol use. 
 Sometimes the only hint of a larger 
underlying problem is overlooked or 
passed off as a minor laboratory variation 
amid other normal results. On more 
than one occasion, I have been able to 
unmask an occult drinking problem by 
paying attention to this parameter on the 
complete blood count. This Clinical Inquiry 
is a good lesson in understanding the 
implications of all of the parameters of a 
CBC, not focusing just on the traditional 
white blood cell count, hematocrit and 
hemoglobin, and platelet counts. 
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❚ Evidence summary
Signifi cant macrocytosis is usually defi ned 
as a mean corpuscular volume greater 
than 99 femtoliters (fL). The prevalence 
of macrocytosis (with or without anemia) 
ranges from 1.7% to 5.0%.1-4 As many 
as 60% to 80% of primary care patients 
may not have anemia.3,4 
Because no study has looked spe-
cifi cally at evaluating macrocytosis 
without anemia, extrapolation from 
studies of all presentations of mac-
rocytosis (with and without ane-
mia) must help guide evaluation.1,3,5-7 
The causes of macrocytosis vary de-
pending on the population studied 
(TABLE). In primary care, alcohol use and 
vitamin defi ciency are common causes. 
Even after evaluation, approximately 
10% of cases remain unexplained.3
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Although 
hypothyroidism 
rarely causes 
macrocytosis, 
it may be more 
prevalent in the 
elderly
Clues in the history, physical 
exam, and lab results
A history focusing specifi cally on alcohol 
use and medications—especially chemo-
therapeutics, antiretroviral drugs, and 
antiseizure medications—can provide 
important clues to the cause of macrocy-
tosis. During the physical examination, 
look for signs consistent with chronic 
liver disease. 
Laboratory studies can help iden-
tify vitamin defi ciencies, liver disease, and 
thyroid disease. A normal serum B12 level 
may not rule out a true B12 defi ciency, but 
normal levels of the metabolites methyl-
malonic acid and homocysteine do essen-
tially rule it out.8 In this era of folic acid 
fortifi cation, the utility of the serum folate 
level is uncertain. Several studies suggest 
empiric treatment with folic acid instead 
of testing for a defi ciency when B12 defi -
ciency has been ruled out.7,9 
Liver disease—which may be con-
founded by alcohol abuse, medications, or 
cancer—is a common cause of macrocyto-
sis.5 Hypothyroidism is rarely a cause, but 
may be more prevalent in the elderly.10
What these 2 tests may, 
or may not, tell you 
Although several authorities recommend 
a peripheral smear and reticulocyte count 
to help evaluate macrocytic anemia, no 
specifi c recommendations exist for these 
tests in the absence of anemia. A pe-
ripheral smear can detect megaloblastic 
changes typical of B12 and folate defi cien-
cy and other marrow disorders, especial-
ly myelodysplastic changes. Peripheral 
smear fi ndings and reticulocytosis can 
also show evidence of hemolysis. How-
ever, megaloblastic changes and marrow-
related changes on peripheral smear are 
typically seen with anemia. 
In 2 prospective studies of primary 
care patients, 1 reported little diagnostic 
value for the peripheral smear,1 and the 
other found that reticulocytosis rarely 
caused macrocytosis.5 A prospective study 
of 300 hospitalized patients with macro-
cytosis found that 100% of marrow dis-
orders and hemolysis that caused macro-
cytosis also caused an associated anemia.7 
A retrospective chart review of 113 cases 
of macrocytosis in outpatients found that 
general practitioners often didn’t order a 
peripheral smear and reticulocyte count to 
complete their diagnostic workups.4
Bone marrow biopsy may reveal 
dysplastic changes, but not a Dx
A prospective study of the utility of bone 
marrow biopsy in 124 elderly patients 
with macrocytosis found that as many 
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as 60% were diagnosed by blood tests 
alone. All the remaining patients with un-
explained macrocytosis underwent bone 
marrow biopsy, which showed early dys-
plastic changes in 39%, but did not pro-
vide a diagnosis in nearly 50%. Twelve 
percent were found to have myelodys-
plastic syndrome, but they had a mean 
hemoglobin of 8.5 g/dL.10
Recommendations
We were unable to fi nd published guide-
lines for the evaluation of macrocytosis 
without anemia by the American Soci-
ety of Hematology, the British Commit-
tee for Standards in Haematology, or in 
an authoritative hematology text.11 ■ 
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As many as 60% 
of elderly patients 
with macrocytosis 
were diagnosed by 
blood test alone
Causes of macrocytosis: What prospective studies show
CAUSE PERCENT OF PATIENTS BY STUDY
DAVIDSON6 
(N=200)
BREEDVELD1 
(N=70)
KEENAN5
(N=80)
SAVAGE7
(N=300)
MAHMOUD10 
(N=124)
Alcohol 18 27 36 26 14
Vitamin deﬁ ciency 13 39 (6% had both 
defi ciencies)
16 6 24
B12 8 23 10 5 12
Folate 5 10 6 1 12
Medications 30 1 —* 37 2
Liver disease 16 3 9 6 2
Hematologic 
disease
15 19 14 14 20
Malignancy/
premalignancy
15 13 11 6 20
Reticulocytosis 0 6 3 8 —†
Hypothyroidism —† 3 6 1 12
Unexplained 23 9 28 7 19
* Excluded patients on cytotoxic and chemotherapeutic medications
† Not evaluated.
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